Filing Flows › Paysign (PAYS) › Q2 2026 › vs Q2 2025
Paysign (PAYS) Q2 2026 vs Q2 2025 (year over year)
Paysign's revenue rose $9.2M (+48%) from $19.1M in Q2 2025 to $28.3M in Q2 2026. The biggest changes: Pharma Industry +$6.9M (+89%); Plasma Industry +$2.3M (+21%); Breakage Revenue +$21K (+38%). Gross margin 63.3% against 61.6% (+1.7 pts).
Paysign, Q2 2026: revenue $28.3M (+48% year over year), operating margin 24.8%, net earnings $6.8M, operating cash flow $1.3M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 63.3% | 61.6% | +1.7 pts |
| Operating margin | 24.8% | 7.5% | +17.3 pts |
| Net margin | 23.9% | 7.3% | +16.6 pts |
| Free cash flow margin | 4.2% | 18.6% | -14.4 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Pharma Industry | $14.6M | $7.8M | $6.9M | +89% |
| Plasma Industry | $13.0M | $10.7M | $2.3M | +21% |
| Other Revenue | $562K | $581K | −$18K | -3% |
| Breakage Revenue | $76K | $55K | $21K | +38% |
| Revenue | $28.3M | $19.1M | $9.2M | +48% |
| Gross profit | $17.9M | $11.8M | $6.1M | +52% |
| Cost of revenue | $10.4M | $7.3M | $3.0M | +41% |
| Other income, net | $894K | $605K | $289K | +48% |
| Operating profit | $7.0M | $1.4M | $5.6M | +388% |
| Operating expenses | $10.9M | $10.3M | $569K | +6% |
| Pre-tax earnings | $7.9M | $2.0M | $5.9M | +287% |
| SG&A | $8.5M | $8.2M | $349K | +4% |
| Other operating costs | $2.3M | $2.1M | $220K | +10% |
| Net earnings | $6.8M | $1.4M | $5.4M | +387% |
| Income tax | $1.1M | $655K | $494K | +75% |
| Operating cash sources | $10.3M | $4.5M | $5.9M | +132% |
| Depreciation & amortization | $2.3M | $2.1M | $220K | +10% |
| Share-based compensation | $1.3M | $954K | $298K | +31% |
| Working capital & other | $9.1M | $821K | $8.2M | 11× |
| Operating cash flow | $1.3M | $3.6M | −$2.3M | -64% |
| Free cash flow (OCF − capex) | $1.2M | $3.6M | −$2.4M | -66% |
| Capital expenditures | $103K | $86K | $17K | +20% |
Questions
How much did Paysign's revenue grow year over year in Q2 2026?
Paysign's revenue rose $9.2M (+48%) from $19.1M in Q2 2025 to $28.3M in Q2 2026.
What drove Paysign's revenue change in Q2 2026?
Pharma Industry +$6.9M (+89%); Plasma Industry +$2.3M (+21%); Breakage Revenue +$21K (+38%).